294 related articles for article (PubMed ID: 16631067)
1. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.
Moshirfar M; Mirzaian G; Feiz V; Kang PC
J Cataract Refract Surg; 2006 Mar; 32(3):515-8. PubMed ID: 16631067
[TBL] [Abstract][Full Text] [Related]
2. Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
Moshirfar M; Meyer JJ; Espandar L
J Cataract Refract Surg; 2007 Nov; 33(11):1978-81. PubMed ID: 17964409
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
[TBL] [Abstract][Full Text] [Related]
4. Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery.
Solomon R; Donnenfeld ED; Perry HD; Rubinfeld RS; Ehrenhaus M; Wittpenn JR; Solomon KD; Manche EE; Moshirfar M; Matzkin DC; Mozayeni RM; Maloney RK
Am J Ophthalmol; 2007 Apr; 143(4):629-34. PubMed ID: 17320811
[TBL] [Abstract][Full Text] [Related]
5. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
Jhanji V; Sharma N; Satpathy G; Titiyal J
J Cataract Refract Surg; 2007 Aug; 33(8):1488-9. PubMed ID: 17662450
[TBL] [Abstract][Full Text] [Related]
6. Infectious keratitis after photorefractive keratectomy in the United States army and navy.
Wroblewski KJ; Pasternak JF; Bower KS; Schallhorn SC; Hubickey WJ; Harrison CE; Torres MF; Barnes SD
Ophthalmology; 2006 Apr; 113(4):520-5. PubMed ID: 16488012
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
[TBL] [Abstract][Full Text] [Related]
8. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas keratitis after laser in situ keratomileusis.
Sharma N; Sinha R; Singhvi A; Tandon R
J Cataract Refract Surg; 2006 Mar; 32(3):519-21. PubMed ID: 16631068
[TBL] [Abstract][Full Text] [Related]
10. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
Lee SB; Oliver KM; Strube YN; Mohan SK; Slomovic AR
Can J Ophthalmol; 2005 Dec; 40(6):750-3. PubMed ID: 16391641
[TBL] [Abstract][Full Text] [Related]
11. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
[TBL] [Abstract][Full Text] [Related]
12. Bilateral methicillin-resistant staphylococcus aureus keratitis in a medical resident following an uneventful bilateral photorefractive keratectomy.
Solomon R; Donnenfeld ED; Perry HD; Biser S
Eye Contact Lens; 2003 Jul; 29(3):187-9. PubMed ID: 12861116
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Moore QC; Norcross EW; Shafiee A; Marquart ME
J Ocul Pharmacol Ther; 2010 Apr; 26(2):193-8. PubMed ID: 20334537
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
Chang VS; Dhaliwal DK; Raju L; Kowalski RP
Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.
Epstein SP; Bottone EJ; Asbell PA
Eye Contact Lens; 2006 Sep; 32(5):240-4. PubMed ID: 16974157
[TBL] [Abstract][Full Text] [Related]
17. Microbial cultures of the microkeratome blade immediately after flap construction in laser in situ keratomileusis.
Khan AM; Larson B; Noth J; Rosen R; Bouchard C
J Cataract Refract Surg; 2008 May; 34(5):842-5. PubMed ID: 18471644
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.
Ray KJ; Prajna L; Srinivasan M; Geetha M; Karpagam R; Glidden D; Oldenburg CE; Sun CQ; McLeod SD; Acharya NR; Lietman TM
JAMA Ophthalmol; 2013 Mar; 131(3):310-3. PubMed ID: 23307105
[TBL] [Abstract][Full Text] [Related]
19. Incidence of corneal infections after laser in situ keratomileusis and surface ablation when moxifloxacin and tobramycin are used as postoperative treatment.
Ortega-Usobiaga J; Llovet-Osuna F; Djodeyre MR; Llovet-Rausell A; Beltran J; Baviera J
J Cataract Refract Surg; 2015 Jun; 41(6):1210-6. PubMed ID: 26096523
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.
Stroman DW; Dajcs JJ; Cupp GA; Schlech BA
Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S16-31. PubMed ID: 16257308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]